Transfusion

• 

  Publication Venue For

  • Transfusion of ABO-group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients..  63 Suppl 3:S46-S53. 2023
  • Blood donation motivators and barriers reported by young, first-time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences..  62:2539-2554. 2022
  • Therapeutic plasma exchange in the management of immune checkpoint inhibitor-associated immune-related adverse effects: A review..  62:2370-2390. 2022
  • Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage..  62:1619-1629. 2022
  • Hospital red blood cell and platelet supply and utilization from March to December of the first year of the COVID-19 pandemic: The BEST collaborative study..  62:1559-1570. 2022
  • The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: A secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial..  62 Suppl 1:S139-S150. 2022
  • Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components..  62:1365-1376. 2022
  • Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery..  62:809-816. 2022
  • Bleeding outcomes of inpatients receiving therapeutic plasma exchange: A propensity-matched analysis of the National Inpatient Sample..  62:386-395. 2022
  • Fear is associated with attrition of first-time whole blood donors: A longitudinal examination of donor confidence and attitude as potential mediators..  61:3372-3380. 2021
  • Promoting awareness of donation-related iron depletion among high risk blood donors..  61:3353-3360. 2021
  • Results from the blood donor competence, autonomy, and relatedness enhancement (blood donor CARE) randomized trial..  61:2637-2649. 2021
  • Blood transfusions in gunshot-wound-related emergency department visits and hospitalizations in the United States..  61:2277-2289. 2021
  • Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population..  61:2008-2013. 2021
  • Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality..  61:1867-1883. 2021
  • Frequency of rare, serious donor reactions: International perspective..  61:1780-1788. 2021
  • COVID-19 convalescent plasma: Interim recommendations from the AABB..  61:1313-1323. 2021
  • Medical chart validation of inpatient diagnosis codes for transfusion-related acute lung injury 2013-2015..  61:754-766. 2021
  • Randomized controlled trial of 7, 28, vs 42 day stored red blood cell transfusion on oxygen delivery (VO2 max) and exercise duration..  61:699-707. 2021
  • Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program..  61:603-616. 2021
  • Evaluation of effect of scheduled fresh frozen plasma on ECMO circuit life: A randomized pilot trial..  61:42-51. 2021
  • Transfusion reactions associated with COVID-19 convalescent plasma therapy for SARS-CoV-2..  61:78-93. 2021
  • Examination of the relationship between iron status and cognitive function among healthy young women with and without a recent history of blood donation..  60:2886-2895. 2020
  • The need for an artificial oxygen carrier for disasters and pandemics, including COVID-19..  60:3039-3045. 2020
  • How do I develop a process to effectively treat parturients with iron deficiency anemia?.  60:2476-2481. 2020
  • Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review..  60:2714-2736. 2020
  • Transfusion of blood components containing ABO-incompatible plasma does not lead to higher mortality in civilian trauma patients..  60:2517-2528. 2020
  • Comparative changes of pre-operative autologous transfusions and peri-operative cell salvage in the United States..  60:2260-2271. 2020
  • Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies..  60:2067-2078. 2020
  • Use of a rapid electronic survey methodology to estimate blood donors' potential exposure to emerging infectious diseases: Application of a statistically representative sampling methodology to assess risk in US blood centers..  60:1987-1997. 2020
  • A randomized controlled trial of a tablet-based intervention to address predonation fears among high school donors..  60:1450-1453. 2020
  • How did we rapidly implement a convalescent plasma program?.  60:1348-1355. 2020
  • Remunerating donors to ensure a safe and available blood supply..  60 Suppl 3:S134-S137. 2020
  • Zika virus and its implications on cord blood banking and transplantation..  60:889-891. 2020
  • Noninvasive white blood cell quantification in umbilical cord blood collection bags with quantitative oblique back-illumination microscopy..  60:588-597. 2020
  • Septic risk increases with apheresis platelet storage time..  60:220-222. 2020
  • The impact of age and sex on first-time donor return behavior..  60:84-93. 2020
  • Metabolic impact of red blood cell exchange with rejuvenated red blood cells in sickle cell patients..  59:3102-3112. 2019
  • An automated motivational interview promotes donation intention and self-efficacy among experienced whole blood donors..  59:2876-2884. 2019
  • Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study..  59:2899-2907. 2019
  • Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee..  59:2733-2748. 2019
  • Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange..  59:2622-2628. 2019
  • Ten years of TRALI mitigation: measuring our progress..  59:2567-2574. 2019
  • Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method..  59:2264-2275. 2019
  • Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature..  59:1907-1910. 2019
  • Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study..  59:1723-1733. 2019
  • Effects of therapeutic plasma exchange on anticoagulants in patients receiving therapeutic anticoagulation: a systematic review..  59:1870-1879. 2019
  • Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery..  59:1209-1222. 2019
  • Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study..  59:1267-1272. 2019
  • Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States..  59:500-507. 2019
  • Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods..  59:762-767. 2019
  • Donor incentives improve cardiovascular disease risk profile and donation rates..  59:250-258. 2019
  • Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism..  58:2797-2806. 2018
  • Blood utilization and mortality in victims of gun violence..  58:2326-2334. 2018
  • Severe anemia associated with increased risk of death and myocardial ischemia in patients declining blood transfusion..  58:2290-2296. 2018
  • Analysis of a large data set to identify predictors of blood transfusion in primary total hip and knee arthroplasty..  58:1855-1862. 2018
  • Metabolomics evaluation of early-storage red blood cell rejuvenation at 4°C and 37°C..  58:1980-1991. 2018
  • Risk-based decision making: a good start to aiding US blood policy decisions?.  58:1827-1830. 2018
  • Changes in plasma unit distributions to hospitals over a 10-year period..  58:1012-1020. 2018
  • Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee..  58:1065-1075. 2018
  • PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets..  58:891-895. 2018
  • Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015..  58:660-668. 2018
  • Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016..  58:255-266. 2018
  • Trends in antigen-negative red blood cell distributions by racial or ethnic groups in the United States..  58:145-150. 2018
  • A motivational interview promotes retention of blood donors with high internal motivation..  57:2433-2439. 2017
  • How do we manage blood donors and recipients after a positive Zika screening result?.  57:2077-2083. 2017
  • Treatment of an acquired Factor XIII inhibitor in an adolescent with systemic lupus erythematosus and renal failure..  57:2159-2163. 2017
  • Trends in age and red blood cell donation habits among several racial/ethnic minority groups in the United States..  57:1644-1655. 2017
  • Impact of predictive scoring model and e-mail messages on African American blood donors..  57:1515-1521. 2017
  • Encouraging single-unit transfusions: a superior patient blood management strategy?.  57:1107-1108. 2017
  • Trends in US minority red blood cell unit donations..  57:1226-1234. 2017
  • Donating blood on a regular basis appears to reduce blood pressure, but appearances can be deceiving..  57:933-937. 2017
  • A randomized controlled pilot study of VO2 max testing: a potential model for measuring relative in vivo efficacy of different red blood cell products..  57:630-636. 2017
  • First cases of Zika virus-infected US blood donors outside states with areas of active transmission..  57:770-778. 2017
  • Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States..  57:289-295. 2017
  • Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers..  57:207-214. 2017
  • Anti-Jka that are detected by solid-phase red blood cell adherence but missed by gel testing can cause hemolytic transfusion reactions..  56:2973-2979. 2016
  • Storage characteristics of multiple-donor pooled red blood cells compared to single-donor red blood cell units..  56:2941-2947. 2016
  • Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States..  56:2781-2789. 2016
  • How transplant centers deal with the dextran shortage: recommendations for comparing alternatives..  56:2657-2661. 2016
  • Changes in blood center red blood cell distributions in the era of patient blood management: the trends for collection (TFC) study..  56:1965-1973. 2016
  • Motivations for donating and attitudes toward screening policies in US blood donors with viral infection..  56:2013-2020. 2016
  • A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors..  56:1875-1882. 2016
  • Inventory management strategies that reduce the age of red blood cell components at the time of transfusion..  56:1758-1762. 2016
  • No association between donor age and recipient outcomes: transfusion of plasma in patients undergoing coronary artery bypass grafting surgery..  56:1723-1729. 2016
  • Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay..  56:1866-1874. 2016
  • A brief motivational interview with action and coping planning components enhances motivational autonomy among volunteer blood donors..  56:1636-1644. 2016
  • Babesia screening: the importance of reporting and calibration in cost-effectiveness models..  56:774-775. 2016
  • Risk-based decision making and ethical considerations in donor compensation for plassma-derived medicinal products.  00. 2016
  • How do we develop and implement a preoperative anemia clinic designed to improve perioperative outcomes and reduce cost?.  56:297-303. 2016
  • Probable and possible transfusion-transmitted dengue associated with NS1 antigen-negative but RNA confirmed-positive red blood cells..  56:215-222. 2016
  • Costs and outcomes after cardiac surgery in patients refusing transfusion compared with those who do not: a case-matched study..  55:2791-2798. 2015
  • Renitrosylation of banked human red blood cells improves deformability and reduces adhesivity..  55:2452-2463. 2015
  • 2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium..  55:2282-2290. 2015
  • Detection of bacterial contamination in apheresis platelets: is apheresis technology a factor?.  55:2113-2122. 2015
  • Retrospective analysis of community hospital red blood cell recovery procedures: improved utilization needed for effectiveness..  55:1972-1979. 2015
  • Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival..  55:1378-1387. 2015
  • Risk factors for retrovirus and hepatitis virus infections in accepted blood donors..  55:1098-1107. 2015
  • Evaluating a program to increase blood donation among racial and ethnic minority communities in New York City..  54:3061-3067. 2014
  • The value of area-based analyses of donation patterns for recruitment strategies..  54:3051-3060. 2014
  • Jehovah's Witnesses and cardiac surgery: a single institution's experience..  54:2745-2752. 2014
  • Randomized study of washing 40- to 42-day-stored red blood cells..  54:2544-2552. 2014
  • Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay..  54:2237-2244. 2014
  • The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine..  54:2344-2352. 2014
  • A comparison of adverse reaction rates for PAS C versus plasma platelet units..  54:1927-1934. 2014
  • The blood donor identity survey: a multidimensional measure of blood donor motivations..  54:2098-2105. 2014
  • Current patterns of use in therapeutic apheresis: a metropolitan center experience..  54:1899-1900. 2014
  • Evaluation and management of postpartum hemorrhage: consensus from an international expert panel..  54:1756-1768. 2014
  • In reply..  54:1443-1444. 2014
  • Reduced use of allogeneic platelets through high-yield perioperative autologous plateletpheresis and reinfusion..  54:1348-1357. 2014
  • Cost-effectiveness of blood donor screening for Babesia microti in endemic regions of the United States..  54:889-899. 2014
  • Development of common metrics for donation attitude, subjective norm, perceived behavioral control, and intention for the blood donation context..  54:839-847. 2014
  • A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia..  54:306-315. 2014
  • In reply..  54:496. 2014
  • Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality..  54:340-352. 2014
  • Acquired peanut hypersensitivity after transfusion..  54:256-257. 2014
  • How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures..  54:17-25. 2014
  • Comparison of visually estimated blood loss with direct hemoglobin measurement in multilevel spine surgery..  53:2790-2794. 2013
  • Why has Borrelia burgdorferi not been transmitted by blood transfusion?.  53:2822-2826. 2013
  • How do I provide leukapheresis products? Blood center experience and evidence for process improvement..  53:2123-2129. 2013
  • Protamine-induced immune thrombocytopenia..  53:2158-2163. 2013
  • Posttransfusion thrombocytopenia: a cautionary tale of female group AB plasma..  53:2105-2106. 2013
  • Transfusion medicine illustrated: Mosaic Trisomy 9 in an infant with mixed-field ABO blood grouping..  53:1884. 2013
  • Practical coagulation for the blood banker..  53:1594-1602. 2013
  • Measuring the processes of change for increasing blood donation in black adults..  53:1280-1290. 2013
  • Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center..  53:1083-1087. 2013
  • Transfusion-related biologic effects and free hemoglobin, heme, and iron..  53:732-740. 2013
  • West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic..  52:2664-2670. 2012
  • Impact of transfusion of autologous 7- versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers..  52:2459-2464. 2012
  • Cardiovascular disease risk assessment and prevention in blood donors..  52:2174-2182. 2012
  • Seasonal association of thrombotic thrombocytopenic purpura..  52:1530-1534. 2012
  • Transfusion-transmitted babesiosis: achieving successful mitigation while balancing cost and donor loss..  52:1404-1407. 2012
  • Implementation of a pediatric trauma massive transfusion protocol: one institution's experience..  52:1228-1236. 2012
  • Demographic differences in estimated blood donor eligibility prevalence in the United States..  52:1050-1061. 2012
  • The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME)..  52:272-283. 2012
  • A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery..  52:14-22. 2012
  • Increased numbers of total nucleated and CD34+ cells in blood group O cord blood: an analysis of neonatal innate factors in the Korean population..  52:76-81. 2012
  • Red blood cell products: consideration of the discrepant temperature ranges permitted for storage versus transport..  52:195-200. 2012
  • 2-(Diethylhexyl)phthalate in blood bags: is this a public health issue?.  51:2510-2517. 2011
  • Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?.  51:1132-1135. 2011
  • Alternate analysis strategies for retrospective assessment of outcomes with a male donor-only plasma policy..  51:444-445. 2011
  • Contribution of attitudinal factors to blood donation in African American church attendees..  51:158-165. 2011
  • Transfusion medicine as a profession: evolution over the past 50 years..  50:2536-2541. 2010
  • A clinical prediction tool to estimate the number of units of red blood cells needed in primary elective coronary artery bypass surgery..  50:2337-2343. 2010
  • Storage age of transfused platelets and outcomes after cardiac surgery..  50:2311-2317. 2010
  • Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders..  50:1980-1987. 2010
  • The African American church as a donation site: motivations and barriers..  50:1240-1248. 2010
  • Demographic variations in blood donor deferrals in a major metropolitan area..  50:881-887. 2010
  • Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients..  50:493-500. 2010
  • Blood component therapy in postpartum hemorrhage..  49:2430-2433. 2009
  • Minority and foreign-born representation among US blood donors: demographics and donation frequency for 2006..  49:2221-2228. 2009
  • A novel mouse model of red blood cell storage and posttransfusion in vivo survival..  49:1546-1553. 2009
  • A prospective, double-blind, randomized clinical feasibility trial of controlling the storage age of red blood cells for transfusion in cardiac surgical patients..  49:1375-1383. 2009
  • Critical evaluation of informed consent forms for adult and minor aged whole blood donation used by United States blood centers..  49:1136-1145. 2009
  • Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?.  49:1070-1075. 2009
  • Plasma exchange in pancreatitis due to hypertriglyceridemia..  49:1022-1023. 2009
  • Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions..  48:1971-1980. 2008
  • Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy..  54:1389-1405. 2014
  • Biology of Factor XIII and clinical manifestations of Factor XIII deficiency..  53:1120-1131. 2013
  • Is preoperative fibrinogen predictive for postoperative bleeding after coronary artery bypass grafting surgery?.  49:2006-2007. 2009
  • Aprotinin vs. tranexamic acid: The controversy continues.  46:319-320. 2006
  • Hemostatic agents.  44:58S-62S. 2004
  • Automated thawing increases recovery of colony-forming units from banked cord blood unit grafts. 2018